Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bet v 1 is the major allergen found in birch (Betula verrucosa) pollen and is responsible for most cases of birch pollen allergy, affecting up to 95% of sensitized individuals. It belongs to the pathogenesis-related protein family PR-10. The precise biological function of Bet v 1 in plants remains unclear but it likely acts as a carrier for hydrophobic ligands—especially plant steroids such as brassinosteroids—which may be important for plant growth regulation and defense responses during stress or pathogen attack. It is recognized by IgE antibodies in allergic individuals and cross-reacts with homologous proteins in fruits, nuts, seeds, and vegetables, leading to oral allergy syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major Birch Pollen Allergen Bet v 1.